38 Followers on Owler
ONL is a Michigan-based clinical-stage biopharmaceutical company that researches and develops novel therapies for the treatment of retinal diseases... Read more
OverviewCompetitorsFundingNews & Insights
ONL is a Michigan-based clinical-stage biopharmaceutical company that researches and develops novel therapies for the treatment of retinal diseases... Read more
ONL Therapeutics President & CEO: David Esposito

President & CEO

David Esposito

CEO Approval Rating

88/100

2006

Private

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
28362834 NAICS listing

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$149.2M

News

Funding
Sep 13, 2024
Benzinga
ONL received $65M in Series D Funding

ONL Therapeutics Competitors

1Ocular
2EyePoint
3Eyevensys
4Quethera
5Kodiak Sciences
6Gyroscope
7Ora
8MacuCLEAR
9Aerpio
10Exonate
Unlock 11 + competitors

Trending Companies